68Ga-labeled DOTA-Peptides and 68Ga-labeled Radiopharmaceuticals for Positron Emission Tomography: Current Status of Research, Clinical Applications, and Future Perspectives
Top Cited Papers
- 1 July 2011
- journal article
- review article
- Published by Elsevier BV in Seminars in Nuclear Medicine
- Vol. 41 (4), 314-321
- https://doi.org/10.1053/j.semnuclmed.2011.02.001
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- The Renaissance of the 68Ge/68Ga Radionuclide Generator Initiates New Developments in 68Ga Radiopharmaceutical ChemistryCurrent Topics in Medicinal Chemistry, 2010
- Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody MoleculesJournal of Nuclear Medicine, 2010
- Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of DiseaseChemical Reviews, 2010
- 68Ga‐PET: a powerful generator‐based alternative to cyclotron‐based PET radiopharmaceuticalsContrast Media & Molecular Imaging, 2008
- Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?European Journal of Nuclear Medicine and Molecular Imaging, 2007
- Ga2O for target, solvent extraction for radiochemical separation and SnO2for the preparation of a68Ge/68Ga generatorJournal of Radioanalytical and Nuclear Chemistry, 2006
- Cyclotron production of 67Ga(III) with a tandem natGe−natZn targetApplied Radiation and Isotopes, 2001
- Radiochemistry of germaniumJournal of Radioanalytical and Nuclear Chemistry, 1996
- A positron cowThe International Journal of Applied Radiation and Isotopes, 1960
- Studies of the metabolism of germaniumArchives of Biochemistry and Biophysics, 1954